Laminin 511 Product List
Species
- Human（5）
Tag
- -（5）
Host
- HEK293（3）
- CHO（2）
Conjugate
- Unconjugated（5）
Grade
- GMP（2）
- PG (pre-GMP)（2）
- RUO（1）
Low Endotoxin
- No（5）
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| Laminin 511 | HOT LA8-H5283L | Human Laminin 511 Protein, premium grade |  Human | HEK293 | $170.00 175ug | |||
| Laminin 511 | HOT LA1-H5314 | Human Laminin 511 Protein, premium grade (Mix & Scale) | Human | CHO | $180.00 175ug | |||
| Laminin 511 | HOTDMF GMP-LA1H36 | GMP Human Laminin 511 Protein (Mix & Scale) | Human | CHO | $330.00 175ug | |||
| Laminin 511 | HOTDMF GMP-LA1H25 | GMP Human Laminin 511 Protein | Human | HEK293 | $390.00 175ug | |||
| Laminin 511 | Human Laminin 511 Protein, Research Grade | Human | HEK293 | $60.00 175ug |
You Have Viewed 1-5 Of 5 Results
Asset Licensing Opportunity
Resources
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| TTX-030 | TTX-030 | Phase 2 Clinical | Adimab LLC | Solid tumours; Pancreatic Neoplasms; Lymphoma | Details |
| IPH-5201 | IPH-5201 | Phase 2 Clinical | Inserm, Orega Biotech | Solid tumours; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| Perenostobart | SRF-617 | Phase 2 Clinical | Surface Oncology Inc | Solid tumours; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms | Details |
| JS-019 | JS-019 | Phase 1 Clinical | Beijing Enrini Biotechnology Co Ltd | Solid tumours; Eosinophilia; Lymphoma | Details |
| ES-014 | ES-014 | Phase 1 Clinical | Solid tumours; Neoplasms; Neoplasm Metastasis | Details | |
| PUR-001 | PUR-001 | Phase 1 Clinical | Purinomia Biotech Inc | Solid tumours | Details |
| AB-598 | AB598 | Phase 1 Clinical | Arcus Biosciences Inc | Ovarian Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms | Details |
| Eurestobart | ES-002023 | Phase 1 Clinical | Solid tumours | Details | |
| ES-002 | ES-002 | Phase 1 Clinical | Solid tumours; Neoplasms | Details |
Customer Reviews